Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2026-02-24 @ 3:14 PM
Study NCT ID:
NCT00095004
Status:
COMPLETED
Last Update Posted:
2024-08-14
First Post:
2004-10-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)
Sponsor:
Organon and Co
Organization:
Study Overview
Official Title:
A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 mg Tablet Administered Early During a Migraine Attack While the Pain is Mild
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: